Song et al. [11] reported that texture features derived from kinetic parameter maps, calculated based on breast DCE-T1W1, can be used as imaging biomarkers to distinguish HER2-positive and HER2-negative breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.